- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Haleon plc(HLN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HLN
11/19/2026: HLN (1-star) is currently NOT-A-BUY. Pass it for now.
Haleon plc is a pure-play consumer healthcare company known for globally recognized everyday brands like Sensodyne, Panadol, and Centrum. The company benefits from resilient defensive demand, strong brand loyalty, and historically robust profit margins. Its primary investment story centers on steady organic growth, margin expansion, and consistent balance sheet deleveraging. Key risks include private-label competition, raw material inflation, and debt service obligations. The stock suits defensive or income-focused investors looking for stable consumer exposure, with ongoing debt reduction and cash generation remaining key developments to monitor.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | Haleon offers steady, mid-single-digit organic growth rather than high-octane hyper-growth characteristics. |
| Momentum investor | Strong fit while signal remains positive | Momentum appeal depends on favorable technical breakouts supported by strong defensive earnings reports. |
| Value investor | Mixed fit | Valuation reflects stable defensive qualities, offering moderate upside depending on debt reduction progress. |
| Dividend investor | Strong fit | The company provides a reliable dividend profile backed by predictable cash flows from everyday health products. |
| Low-risk investor | Strong fit | Essential consumer healthcare products provide lower cyclical volatility compared to discretionary or tech sectors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Low | Defensive consumer staples traits generally shield the stock from sharp macro market swings. |
| Valuation risk | Medium | Shares can experience multiple compression if broader market interest rates rise significantly. |
| Competition risk (branded vs store-brands) | Medium / high | Retailer private-label alternatives continuously pressure market share during tight consumer budget cycles. |
| Business quality | Strong | A portfolio of globally trusted household names underpins robust franchise durability. |
| Dividend income | Medium | Payouts are stable and backed by predictable cash generation, though yields remain moderate. |
| Execution risk | Medium | Successful margin expansion relies heavily on effective supply chain management and cost discipline. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 39.74B USD | Price to earnings Ratio 18.5 | 1Y Target Price 10.4 |
Price to earnings Ratio 18.5 | 1Y Target Price 10.4 | ||
Volume (30-day avg) 20.6M shares | Beta 0.29 | 52 Weeks Range 8.38 - 11.06 | Updated Date 11/19/2026 |
52 Weeks Range 8.38 - 11.06 | Updated Date 11/19/2026 | ||
Dividends yield (FY) 2.18% | Basic EPS (TTM) 0.49 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 61.0%
- Active BUY / eligible
- 64 / 105
- 30-Day BUY Count Change
- +16
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Drug Manufacturers - Specialty & Generic
- BUY participation
- 91.7%
- Active BUY / eligible
- 11 / 12
- 30-Day BUY Count Change
- +5
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -23.83% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Oral Health | Global sales of toothpaste, mouthwashes, and toothbrushes under brands like Sensodyne and Parodontax. | This is a primary profit driver underpinned by daily consumer habit routines. |
| Pain Relief | Over-the-counter analgesic medications and topical gels such as Panadol and Voltaren. | Provides high-margin, consistent cash flow across seasonal cold and flu periods. |
| Vitamins, Minerals and Supplements (VMS) | Nutritional products marketed globally under names like Centrum and Caltrate. | Captures secular wellness and preventative health spending trends. |
| Respiratory and Digestive Health | Remedies targeting cold, flu, and gastrointestinal ailments including Theraflu and ENO. | Revenue fluctuates somewhat with seasonal illness outbreaks. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 18.5 | Forward PE 15.27 | Enterprise Value 49.50B | Price to Sales(TTM) 3.56 |
Enterprise Value 49.50B | Price to Sales(TTM) 3.56 | ||
Enterprise Value to Revenue 3.39 | Enterprise Value to EBITDA 13.46 | Shares Outstanding 4.38B | Shares Floating 4.43B |
Shares Outstanding 4.38B | Shares Floating 4.43B | ||
Percent Insiders 0.03 | Percent Institutions 15.71 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

